BURZYNSKI RESEARCH INSTITUTE INC (BZYR)

↓ Download CSV

CIK 0000724445 · OTC · In Vitro & In Vivo Diagnostic Substances

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Feb 28

In fiscal 2025, BURZYNSKI RESEARCH INSTITUTE INC reported revenue of $0. The company ran a net loss. It held $847 in total assets against $42.5K in total liabilities.

Metric (FY)2025202420232022202120202019201820172016
Revenue$0$0$0$0$0$0$0$0$0$0
Operating Income-$1.39M-$1.34M-$916.3K-$976.7K-$1.30M-$1.63M-$1.64M-$1.61M-$1.50M-$2.01M
Net Income-$1.39M-$1.34M-$916.3K
EPS (Diluted)$-0.01$-0.01$-0.01$-0.01$-0.01
Total Assets$847$2.3K$1.9K$4.7K$956$19.9K$22.2K$28.9K$10.7K$4.0K
Total Liabilities$42.5K$27.4K$15.7K$3.5K$46.8K$172.4K$208.8K$136.6K$43.7K$105.0K
Shareholders' Equity-$41.6K-$25.1K-$13.7K$1.2K-$45.8K-$152.6K-$186.6K-$107.7K-$33.0K-$101.0K
Cash & Equivalents$847$1.3K$934$3.4K$62$163$708$506$731$3.3K
Operating Cash Flow-$388.5K-$523.8K-$249.5K-$325.1K-$394.4K-$530.1K-$477.5K-$319.5K-$314.5K
Shares Outstanding131.45M131.45M131.45M131.45M131.45M131.45M131.45M131.45M131.45M131.45M